Fish oil may delay hormone therapy in prostate cancer patients
NCT ID NCT03753334
First seen Nov 25, 2025 · Last updated Apr 25, 2026 · Updated 18 times
Summary
This study tests whether a daily high-dose omega-3 supplement (fish oil) can slow the rise of PSA levels in men whose prostate cancer has returned after initial treatment. About 40 men with a rising PSA but no visible spread will take either the supplement or a placebo for one year. The goal is to see if omega-3s can delay the need for hormone therapy, which often has harsh side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Recherche Clinique et Évaluative en Oncologie - Hôtel-Dieu de Québec
Québec, Quebec, G1R 3S1, Canada
Conditions
Explore the condition pages connected to this study.